Viewing Study NCT04176718


Ignite Creation Date: 2025-12-25 @ 4:41 AM
Ignite Modification Date: 2026-02-28 @ 11:15 AM
Study NCT ID: NCT04176718
Status: RECRUITING
Last Update Posted: 2025-10-07
First Post: 2019-11-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Sponsor: Andrew Yee, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module